research communications
of 4-amino-5-fluoro-2-oxo-2,3-dihydropyrimidin-1-ium 3-hydroxypyridine-2-carboxylate
aSchool of Chemistry, Bharathidasan University, Tiruchirappalli 620 024, Tamilnadu, India, bFaculty of Chemistry and Chemical Technology, University of Ljubljana, Vecna pot 113, PO Box 537, SI-1000 Ljubljana, Slovenia, and cCO EN-FIST, Trg Osvobodilne fronte 13, SI-1000 Ljubljana, Slovenia
*Correspondence e-mail: tommtrichy@yahoo.co.in
The 4H5FN3O+·C6H4NO3−, contains one 4-amino-5-fluoro-2-oxo-2,3-dihydropyrimidin-1-ium (5-fluorocytosinium, 5FC) cation and a 3-hydroxypicolinate (3HAP) anion. The 4-amino-5-fluoro-2-oxo-2,3-dihydropyrimidine molecule is protonated at one of the pyrimidine N atoms. The typical intramolecular N—H⋯F and O—H⋯O S(5) and S(6) hydrogen-bond ring motifs are observed in the cations and anions. The protonated N atom and 2-amine group of the 5FC cation interact with the 3HPA anion through a pair of nearly parallel N—H⋯O hydrogen bonds, forming a robust R22(8) ring motif. The ions are further linked by N—H⋯N, O—H⋯O, N—H⋯O and C—H⋯O hydrogen bonds, generating R22(7), R33(12) and R65(18) ring motifs, respectively, leading to supramolecular wave-like sheets parallel to (010). The is further stabilized by C—H⋯π interactions, generating a three-dimensional architecture.
of the title salt, CKeywords: crystal structure; antifungal drug; 5-fluorocytosine; hydrogen bonding; supramolecular structure; hydrogen-bond ring motifs; crystal structure.
CCDC reference: 1027535
1. Chemical context
Fluorinated pyrimidine and purine derivatives have received much interest because of their wide range of biological applications (Giner-Sorolla & Bendich, 1958). 5-Fuorocytosine is a fluorinated pyrimidine derivative anti-metabolite drug and is also extensively used as an anti-fungal agent for the treatment of Candida and Cryptococcus (Vermes et al., 2000). 5-Fluorocytosine is a versatile molecule that plays essential roles in many biological applications, such as anti-tumour, potential gene therapy and gene-directed prodrug therapy (GDEPT) in the treatment of cancer (Kohila et al., 2012). The crystal structures of 5-fluorocytosine monohydrate, 5-fluorocytosine co-crystals and salts have also been reported (Louis et al., 1982; Tutughamiarso et al., 2012; Perumalla & Sun, 2014; Prabakaran et al., 2001). The crystal structures of various salts and complexes of 3-hydroxypicolinic acid have also been reported (Quintal et al., 2000; Soares-Santos et al., 2003; Betz and Gerber, 2011; Nirmalram et al., 2011).
We report herein the molecular structure of the title salt, formed from the reaction of 5-fluorocytosine with 3-hydroxypicoinic acid, namely 5-fluorocytosinium 3-hydroxypicolinate.
2. Structural commentary
The ). The 5-fluorocytosine molecule is protonated at N3, as is evident from the increase in the internal angle at N3 from 120.8 (5) in neutral 5-fluorocytosine (Louis et al., 1982) to 124.85 (15)°. There is an intramolecular N—H⋯F hydrogen bond with an S(5) ring motif between the N4 amino group and the F atom of the 5-fluorocytosinum cation. These hydrogen-bonding parameters are similar to those observed in 5-fluorocytosinium salicylate (Prabakaran et al., 2001). An intramolecular O—H⋯O interaction forms an S(6) motif between the phenolic OH and carboxylate group, which is also observed in 3-hydroxypyridinium-2-carboxylate (Betz & Gerber, 2011).
contains a 5-fluorocytosinium cation and a 3-hydroxypicolinate anion (Fig. 13. Supramolecular features
In the ; Bernstein et al., 1995). The 3-hydroxypicolinate (N2 and C12) atoms interact with the N1 atom and the exocyclic oxygen O2 atom of the 5-fluorocytosinium moiety through a pair of N—H⋯N and C—H⋯O hydrogen bonds, forming an (7) motif. This type of motif rarely occurs in cytosinium carboxylate interactions (Benali-Cherif et al., 2009). The motif is further connected on the other side by R33(12) and R56(18) motifs formed (Bernstein et al., 1995) through C—H⋯O and N—H⋯O hydrogen bonds involving the O2 and N4 atoms of the 5-fluorocytosinium cation and the symmetry-related C6 atom of the another cytosinium cation and O1 atoms of 3-hydroxypicolinate anions, generating a wavy sheet-like structure parallel to (010) (Fig. 2). These wavy sheets are interconnected via C10—H10⋯O2 hydrogen bonds (Fig. 3). The is further stabilized by C—H⋯π interactions between 3-hydroxypicolinate anions, Table 1, Fig. 4.
the carboxylate group of the 3-hydroxypicolinate anion (O3 and O4) interacts with the protonated N3 atom and the 4-amino group of the 5-fluorocytosinium moiety through a pair of N—H⋯O hydrogen bonds, forming a robust (8) motif (Etter, 19904. Synthesis and crystallization
Hot aqueous solutions of 5-fluorocytosine (32 mg, Alfa Aesar) and 3-hydroxypicolinic acid (37 mg, Alfa Aesar) were mixed in a 1:1 molar ratio. The resulting solution was warmed over a water bath for half an hour and then kept at room temperature for crystallization. After a week, colourless prismatic crystals were obtained.
5. Refinement
Crystal data, data collection and structure . All H atoms were initially located in difference Fourier maps and were subsequently treated as riding atoms in geometrically idealized positions, with C—H = 0.93, N—H = 0.86 and O—H = 0.83 Å, and with Uiso(H) = 1.2Ueq(C,N) and Uiso(H) = 1.5Ueq(O).
details are summarized in Table 2
|
Supporting information
CCDC reference: 1027535
10.1107/S1600536814021898/tk5344sup1.cif
contains datablock I. DOI:Structure factors: contains datablock I. DOI: 10.1107/S1600536814021898/tk5344Isup2.hkl
Supporting information file. DOI: 10.1107/S1600536814021898/tk5344Isup3.cml
Fluorinated pyrimidine and purine derivatives have received much interest because of their wide range of biological applications (Giner-Sorolla & Bendich, 1958). 5-Fuorocytosine is a fluorinated pyrimidine derivative anti-metabolite drug and is also extensively used as an anti-fungal agent for the treatment of Candida and Cryptococcus (Vermes et al., 2000). 5-Flurocytosine is a versatile molecule that plays essential roles in many biological applications, such as anti-tumour, potential gene therapy and gene-directed prodrug therapy (GDEPT) in the treatment of cancer (Kohila et al., 2012). The crystal structures of 5-fluorocytosine monohydrate, 5-flurocytosine co-crystals and salts have also been reported (Louis et al., 1982; Tutughamiarso et al., 2012; Perumalla & Sun, 2014; Prabakaran et al., 2001). The crystal structures of various salts and complexes of 3-hydroxypicolinc acid have also been reported (Quintal et al., 2000; Soares-Santos et al., 2003; Betz and Gerber, 2011; Nirmalram et al., 2011). We report here the molecular structure of a salt, (I), formed from the reaction of 5-fluorocytosine with 3-hydroxypicoinic acid, namely 5-fluorocytosinium 3-hydroxypicolinate.
The
of (I) contains an 5-fluorocytosinium molecule and a 3-hydroxypicolininate anion (Fig. 1). The 5-fluorocytosine molecule is protonated at N3, as is evident from the increase in the internal angle at N3 from 120.8 (5) neutral 5-fluorocytosine (Louis et al., 1982) to 124.85 (15)°. There is an intramolecular N—H···F hydrogen bond with an S(5) ring motif between the N4 amino group and the F atom of the 5-fluorocytosinum cation. These hydrogen-bonding parameters are in agreement those in with 5-fluorocytosinium salicylate (Prabakaran et al., 2001). An intramolecular O—H···O interaction forms an S(6) motif between the phenolic OH and carboxylate groups, which is also observed in 3-hydroxypyridinium-2-carboxylate (Betz & Gerber, 2011).In the π interactions between 3-hydroxypicolinate anions, Table 1.
the carboxylate group of the 3-hydroxypicolinate anion (O3 and O4) interacts with the protonated N3 atom and the 4-amino group of the 5-fluorocytosinium moiety through a pair of N—H···O hydrogen bonds, forming a robust R22(8) motif (Etter, 1990; Bernstein et al., 1995). The 3-hydroxypicolinate (N2 and C12) atoms interact with the N1 atom and the exocyclic oxygen O2 atom of the 5-fluorocytosinium moiety through a pair of N—H···N and C—H···O hydrogen bonds, forming an R22(7) motif. This type of motif rarely occurs in cytosinium carboxylate interactions (Benali-Cherif et al., 2009). The motif is further connected on the other side by R33(12) and R56(18) motifs (Bernstein et al., 1995) formed through C—H···O and N—H···O hydrogen bonds involving the O2 and N4 atoms of the 5-fluorocytosinium cation and the symmetry-related C6 atom of the another cytosine cation and O1 atoms of 3-hydroxypicolinate anions, generating a wavy sheet-like structure parallel to (010) [OK?] (Fig. 2). These wavy sheets are interconnected via C10—H10···O2 hydrogen bonds (Fig. 3). The is further stabilized by C—H···Hot aqueous solutions of 5-fluorocytosine (32 mg, Alfa Aesar) and 3-hydroxypicolinicacid (37 mg, Alfa Aesar) were mixed in a 1:1 molar ratio. The resulting solution was warmed over a water bath for half an hour and then kept at room temperature for crystallization. After a week, colourless prismatic crystals were obtained.
Crystal data, data collection and structure
details are summarized in Table 2. All H atoms were initially located in difference Fourier maps and were subsequently treated as riding atoms in geometrically idealized positions, with C—H = 0.93, N—H = 0.86 and O—H = 0.83 Å, and with Uiso(H) = 1.2Ueq(C,N) and Uiso(H) = 1.5Ueq(O).Data collection: CrysAlis PRO (Agilent, 2011); cell
CrysAlis PRO (Agilent, 2011); data reduction: CrysAlis PRO (Agilent, 2011); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: PLATON (Spek, 2009); software used to prepare material for publication: PLATON (Spek, 2009).The asymmetric unit of the title compound, showing 30% probability displacement ellipsoids. Dashed lines represent hydrogen bonds. A view of the supramolecular wavy sheet-like structure formed by N—H···F, O—H···O, N—H···O, N—H···N and C—H···O hydrogen bonds. Symmetry codes are given in Table 1. Dashed lines represent hydrogen bonds. The wavy sheets interlinked by C—H···O hydrogen bonds. Dashed lines represent hydrogen bonds. A view of the C—H···π interactions shown as dashed lines. Symmetry codes are given in Table 1. |
C4H5FN3O+·C6H4NO3− | F(000) = 1104 |
Mr = 268.21 | Dx = 1.678 Mg m−3 |
Orthorhombic, Pbca | Mo Kα radiation, λ = 0.71073 Å |
Hall symbol: -P 2ac 2ab | Cell parameters from 3551 reflections |
a = 12.6487 (4) Å | θ = 3.7–29.7° |
b = 7.0786 (2) Å | µ = 0.14 mm−1 |
c = 23.7200 (6) Å | T = 293 K |
V = 2123.77 (10) Å3 | Needle, colourless |
Z = 8 | 0.15 × 0.05 × 0.05 mm |
Agilent SuperNova (Dual, Cu at zero, Atlas) diffractometer | 2437 independent reflections |
Radiation source: SuperNova (Mo) X-ray Source | 1955 reflections with I > 2σ(I) |
Mirror monochromator | Rint = 0.027 |
Detector resolution: 10.4933 pixels mm-1 | θmax = 27.5°, θmin = 3.2° |
ω scans | h = −16→11 |
Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2011) | k = −9→6 |
Tmin = 0.979, Tmax = 0.993 | l = −30→30 |
8914 measured reflections |
Refinement on F2 | Primary atom site location: structure-invariant direct methods |
Least-squares matrix: full | Secondary atom site location: difference Fourier map |
R[F2 > 2σ(F2)] = 0.042 | Hydrogen site location: inferred from neighbouring sites |
wR(F2) = 0.111 | H-atom parameters constrained |
S = 1.08 | w = 1/[σ2(Fo2) + (0.0458P)2 + 0.8599P] where P = (Fo2 + 2Fc2)/3 |
2437 reflections | (Δ/σ)max < 0.001 |
173 parameters | Δρmax = 0.24 e Å−3 |
0 restraints | Δρmin = −0.19 e Å−3 |
C4H5FN3O+·C6H4NO3− | V = 2123.77 (10) Å3 |
Mr = 268.21 | Z = 8 |
Orthorhombic, Pbca | Mo Kα radiation |
a = 12.6487 (4) Å | µ = 0.14 mm−1 |
b = 7.0786 (2) Å | T = 293 K |
c = 23.7200 (6) Å | 0.15 × 0.05 × 0.05 mm |
Agilent SuperNova (Dual, Cu at zero, Atlas) diffractometer | 2437 independent reflections |
Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2011) | 1955 reflections with I > 2σ(I) |
Tmin = 0.979, Tmax = 0.993 | Rint = 0.027 |
8914 measured reflections |
R[F2 > 2σ(F2)] = 0.042 | 0 restraints |
wR(F2) = 0.111 | H-atom parameters constrained |
S = 1.08 | Δρmax = 0.24 e Å−3 |
2437 reflections | Δρmin = −0.19 e Å−3 |
173 parameters |
Experimental. 185 frames in 5 runs of ω scans. Crystal-detector distance = 55.0 mm. |
Geometry. All s.u.'s (except the s.u. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell s.u.'s are taken into account individually in the estimation of s.u.'s in distances, angles and torsion angles; correlations between s.u.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell s.u.'s is used for estimating s.u.'s involving l.s. planes. |
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger. |
x | y | z | Uiso*/Ueq | ||
F1 | −0.04979 (8) | 0.58078 (18) | 0.39473 (5) | 0.0483 (3) | |
N1 | 0.10109 (11) | 0.8014 (2) | 0.50442 (6) | 0.0335 (3) | |
H1 | 0.0909 | 0.8491 | 0.5373 | 0.040* | |
N3 | 0.21136 (11) | 0.7249 (2) | 0.42943 (6) | 0.0312 (3) | |
H3 | 0.2733 | 0.7239 | 0.4145 | 0.037* | |
N4 | 0.14821 (12) | 0.5828 (2) | 0.34880 (6) | 0.0392 (4) | |
H4A | 0.2108 | 0.5846 | 0.3347 | 0.047* | |
H4B | 0.0966 | 0.5360 | 0.3298 | 0.047* | |
O2 | 0.27785 (10) | 0.8667 (2) | 0.50714 (5) | 0.0446 (4) | |
C2 | 0.20128 (14) | 0.8021 (3) | 0.48270 (7) | 0.0317 (4) | |
C4 | 0.13147 (14) | 0.6513 (2) | 0.39922 (7) | 0.0296 (4) | |
C5 | 0.03071 (13) | 0.6548 (3) | 0.42474 (7) | 0.0332 (4) | |
C6 | 0.01722 (14) | 0.7286 (3) | 0.47624 (7) | 0.0346 (4) | |
H6 | −0.0496 | 0.7299 | 0.4926 | 0.041* | |
O1 | 0.49981 (11) | 0.4529 (2) | 0.24635 (5) | 0.0430 (4) | |
H1A | 0.4410 | 0.4833 | 0.2578 | 0.064* | |
O3 | 0.36400 (10) | 0.5738 (2) | 0.31741 (5) | 0.0408 (3) | |
O4 | 0.41321 (10) | 0.6570 (2) | 0.40413 (5) | 0.0416 (3) | |
N2 | 0.61308 (11) | 0.5297 (2) | 0.38561 (6) | 0.0296 (3) | |
C7 | 0.43231 (13) | 0.5915 (3) | 0.35634 (7) | 0.0301 (4) | |
C8 | 0.54219 (13) | 0.5251 (2) | 0.34318 (7) | 0.0274 (4) | |
C9 | 0.56959 (14) | 0.4572 (3) | 0.28970 (7) | 0.0306 (4) | |
C10 | 0.67182 (14) | 0.3927 (3) | 0.28059 (7) | 0.0347 (4) | |
H10 | 0.6918 | 0.3464 | 0.2455 | 0.042* | |
C11 | 0.74279 (14) | 0.3982 (3) | 0.32407 (7) | 0.0339 (4) | |
H11 | 0.8118 | 0.3565 | 0.3189 | 0.041* | |
C12 | 0.71035 (14) | 0.4669 (3) | 0.37608 (7) | 0.0332 (4) | |
H12 | 0.7589 | 0.4690 | 0.4055 | 0.040* |
U11 | U22 | U33 | U12 | U13 | U23 | |
F1 | 0.0265 (6) | 0.0690 (8) | 0.0494 (7) | −0.0079 (5) | −0.0027 (5) | −0.0139 (6) |
N1 | 0.0293 (8) | 0.0439 (9) | 0.0272 (7) | 0.0025 (7) | 0.0027 (6) | −0.0036 (6) |
N3 | 0.0221 (7) | 0.0427 (8) | 0.0288 (7) | −0.0005 (6) | 0.0025 (5) | −0.0008 (6) |
N4 | 0.0295 (8) | 0.0552 (10) | 0.0330 (8) | −0.0036 (8) | 0.0024 (6) | −0.0086 (7) |
O2 | 0.0291 (7) | 0.0668 (9) | 0.0379 (7) | −0.0048 (7) | −0.0022 (5) | −0.0131 (7) |
C2 | 0.0278 (9) | 0.0392 (9) | 0.0280 (8) | 0.0024 (8) | 0.0003 (7) | 0.0009 (7) |
C4 | 0.0278 (9) | 0.0330 (9) | 0.0280 (8) | 0.0017 (7) | −0.0008 (6) | 0.0039 (7) |
C5 | 0.0238 (8) | 0.0406 (10) | 0.0351 (9) | −0.0010 (8) | −0.0034 (7) | −0.0001 (8) |
C6 | 0.0249 (8) | 0.0426 (10) | 0.0362 (9) | 0.0019 (8) | 0.0043 (7) | 0.0038 (8) |
O1 | 0.0331 (7) | 0.0677 (9) | 0.0280 (6) | 0.0063 (7) | −0.0043 (5) | −0.0070 (6) |
O3 | 0.0251 (6) | 0.0644 (9) | 0.0329 (7) | 0.0030 (6) | −0.0020 (5) | 0.0009 (6) |
O4 | 0.0275 (7) | 0.0623 (9) | 0.0349 (7) | 0.0053 (6) | 0.0032 (5) | −0.0091 (6) |
N2 | 0.0244 (7) | 0.0380 (8) | 0.0265 (7) | −0.0016 (6) | 0.0002 (5) | 0.0011 (6) |
C7 | 0.0247 (8) | 0.0361 (9) | 0.0294 (8) | −0.0013 (7) | 0.0015 (7) | 0.0045 (7) |
C8 | 0.0238 (8) | 0.0326 (9) | 0.0258 (8) | −0.0020 (7) | 0.0014 (6) | 0.0024 (7) |
C9 | 0.0292 (9) | 0.0367 (9) | 0.0258 (8) | −0.0007 (8) | −0.0012 (6) | 0.0007 (7) |
C10 | 0.0357 (10) | 0.0394 (10) | 0.0290 (8) | 0.0047 (8) | 0.0048 (7) | −0.0026 (7) |
C11 | 0.0257 (9) | 0.0375 (9) | 0.0386 (9) | 0.0058 (8) | 0.0028 (7) | 0.0011 (8) |
C12 | 0.0267 (9) | 0.0411 (10) | 0.0319 (9) | 0.0005 (8) | −0.0030 (7) | 0.0012 (8) |
F1—C5 | 1.348 (2) | O1—C9 | 1.355 (2) |
N1—C6 | 1.356 (2) | O1—H1A | 0.8200 |
N1—C2 | 1.368 (2) | O3—C7 | 1.271 (2) |
N1—H1 | 0.8600 | O4—C7 | 1.248 (2) |
N3—C4 | 1.344 (2) | N2—C12 | 1.328 (2) |
N3—C2 | 1.383 (2) | N2—C8 | 1.348 (2) |
N3—H3 | 0.8600 | C7—C8 | 1.500 (2) |
N4—C4 | 1.308 (2) | C8—C9 | 1.400 (2) |
N4—H4A | 0.8600 | C9—C10 | 1.388 (2) |
N4—H4B | 0.8600 | C10—C11 | 1.368 (2) |
O2—C2 | 1.218 (2) | C10—H10 | 0.9300 |
C4—C5 | 1.411 (2) | C11—C12 | 1.388 (2) |
C5—C6 | 1.340 (2) | C11—H11 | 0.9300 |
C6—H6 | 0.9300 | C12—H12 | 0.9300 |
C6—N1—C2 | 122.73 (15) | C9—O1—H1A | 109.5 |
C6—N1—H1 | 118.6 | C12—N2—C8 | 118.75 (14) |
C2—N1—H1 | 118.6 | O4—C7—O3 | 124.40 (16) |
C4—N3—C2 | 124.84 (15) | O4—C7—C8 | 118.99 (15) |
C4—N3—H3 | 117.6 | O3—C7—C8 | 116.60 (15) |
C2—N3—H3 | 117.6 | N2—C8—C9 | 121.32 (15) |
C4—N4—H4A | 120.0 | N2—C8—C7 | 116.96 (14) |
C4—N4—H4B | 120.0 | C9—C8—C7 | 121.70 (15) |
H4A—N4—H4B | 120.0 | O1—C9—C10 | 118.77 (15) |
O2—C2—N1 | 123.98 (16) | O1—C9—C8 | 122.25 (16) |
O2—C2—N3 | 120.68 (16) | C10—C9—C8 | 118.98 (15) |
N1—C2—N3 | 115.34 (15) | C11—C10—C9 | 118.99 (16) |
N4—C4—N3 | 120.63 (16) | C11—C10—H10 | 120.5 |
N4—C4—C5 | 123.02 (16) | C9—C10—H10 | 120.5 |
N3—C4—C5 | 116.34 (15) | C10—C11—C12 | 119.08 (16) |
C6—C5—F1 | 122.47 (16) | C10—C11—H11 | 120.5 |
C6—C5—C4 | 120.85 (16) | C12—C11—H11 | 120.5 |
F1—C5—C4 | 116.68 (15) | N2—C12—C11 | 122.87 (16) |
C5—C6—N1 | 119.89 (16) | N2—C12—H12 | 118.6 |
C5—C6—H6 | 120.1 | C11—C12—H12 | 118.6 |
N1—C6—H6 | 120.1 | ||
C6—N1—C2—O2 | 179.95 (18) | C12—N2—C8—C7 | 178.04 (16) |
C6—N1—C2—N3 | 0.7 (3) | O4—C7—C8—N2 | 4.0 (2) |
C4—N3—C2—O2 | −179.68 (17) | O3—C7—C8—N2 | −174.95 (16) |
C4—N3—C2—N1 | −0.4 (3) | O4—C7—C8—C9 | −177.49 (17) |
C2—N3—C4—N4 | 179.33 (17) | O3—C7—C8—C9 | 3.6 (3) |
C2—N3—C4—C5 | 0.0 (3) | N2—C8—C9—O1 | −179.39 (16) |
N4—C4—C5—C6 | −179.16 (18) | C7—C8—C9—O1 | 2.2 (3) |
N3—C4—C5—C6 | 0.2 (3) | N2—C8—C9—C10 | 0.3 (3) |
N4—C4—C5—F1 | 0.8 (3) | C7—C8—C9—C10 | −178.17 (16) |
N3—C4—C5—F1 | −179.85 (15) | O1—C9—C10—C11 | 179.43 (17) |
F1—C5—C6—N1 | −179.86 (16) | C8—C9—C10—C11 | −0.3 (3) |
C4—C5—C6—N1 | 0.1 (3) | C9—C10—C11—C12 | 0.4 (3) |
C2—N1—C6—C5 | −0.5 (3) | C8—N2—C12—C11 | 0.7 (3) |
C12—N2—C8—C9 | −0.5 (3) | C10—C11—C12—N2 | −0.7 (3) |
Cg is the centroid of the N2/C8–C12 ring. |
D—H···A | D—H | H···A | D···A | D—H···A |
N1—H1···N2i | 0.86 | 2.04 | 2.873 (2) | 163 |
N3—H3···O4 | 0.86 | 1.85 | 2.6665 (18) | 158 |
N4—H4A···O3 | 0.86 | 1.98 | 2.830 (2) | 169 |
N4—H4B···O1ii | 0.86 | 2.26 | 3.076 (2) | 159 |
N4—H4B···F1 | 0.86 | 2.43 | 2.7312 (18) | 101 |
O1—H1A···O3 | 0.82 | 1.83 | 2.5542 (18) | 146 |
C6—H6···O2i | 0.93 | 2.29 | 3.127 (2) | 150 |
C10—H10···O3iii | 0.93 | 2.54 | 3.272 (2) | 136 |
C12—H12···O2iv | 0.93 | 2.39 | 3.129 (2) | 137 |
Cll—H11···Cg1v | 0.93 | 2.88 | 3.426 (2) | 119 |
Symmetry codes: (i) x−1/2, −y+3/2, −z+1; (ii) x−1/2, y, −z+1/2; (iii) −x+1, y−1/2, −z+1/2; (iv) x+1/2, −y+3/2, −z+1; (v) −x+3/2, y−1/2, z. |
Cg is the centroid of the N2/C8–C12 ring. |
D—H···A | D—H | H···A | D···A | D—H···A |
N1—H1···N2i | 0.86 | 2.04 | 2.873 (2) | 163 |
N3—H3···O4 | 0.86 | 1.85 | 2.6665 (18) | 158 |
N4—H4A···O3 | 0.86 | 1.98 | 2.830 (2) | 169 |
N4—H4B···O1ii | 0.86 | 2.26 | 3.076 (2) | 159 |
N4—H4B···F1 | 0.86 | 2.43 | 2.7312 (18) | 101 |
O1—H1A···O3 | 0.82 | 1.83 | 2.5542 (18) | 146 |
C6—H6···O2i | 0.93 | 2.29 | 3.127 (2) | 150 |
C10—H10···O3iii | 0.93 | 2.54 | 3.272 (2) | 136 |
C12—H12···O2iv | 0.93 | 2.39 | 3.129 (2) | 137 |
Cll—H11···Cg1v | 0.93 | 2.88 | 3.426 (2) | 119 |
Symmetry codes: (i) x−1/2, −y+3/2, −z+1; (ii) x−1/2, y, −z+1/2; (iii) −x+1, y−1/2, −z+1/2; (iv) x+1/2, −y+3/2, −z+1; (v) −x+3/2, y−1/2, z. |
Experimental details
Crystal data | |
Chemical formula | C4H5FN3O+·C6H4NO3− |
Mr | 268.21 |
Crystal system, space group | Orthorhombic, Pbca |
Temperature (K) | 293 |
a, b, c (Å) | 12.6487 (4), 7.0786 (2), 23.7200 (6) |
V (Å3) | 2123.77 (10) |
Z | 8 |
Radiation type | Mo Kα |
µ (mm−1) | 0.14 |
Crystal size (mm) | 0.15 × 0.05 × 0.05 |
Data collection | |
Diffractometer | Agilent SuperNova (Dual, Cu at zero, Atlas) diffractometer |
Absorption correction | Multi-scan (CrysAlis PRO; Agilent, 2011) |
Tmin, Tmax | 0.979, 0.993 |
No. of measured, independent and observed [I > 2σ(I)] reflections | 8914, 2437, 1955 |
Rint | 0.027 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.042, 0.111, 1.08 |
No. of reflections | 2437 |
No. of parameters | 173 |
H-atom treatment | H-atom parameters constrained |
Δρmax, Δρmin (e Å−3) | 0.24, −0.19 |
Computer programs: CrysAlis PRO (Agilent, 2011), SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), PLATON (Spek, 2009).
Acknowledgements
AK thanks the UGC–SAP, India, for the award of an RFSMS. PTM is thankful to the UGC, New Delhi, for a UGC–BSR one-time grant to Faculty. FP thanks the Slovenian Research Agency for financial support (P1–0230–0175), as well as the EN–FIST Centre of Excellence, Trg Osvobodilne fronte 13, 1000 Ljubljana, Slovenia, for use of the SuperNova diffractometer.
References
Agilent (2011). CrysAlis PRO. Agilent Technologies UK Ltd, Yarnton, England. Google Scholar
Benali-Cherif, N., Falek, W. & Direm, A. (2009). Acta Cryst. E65, o3058–o3059. Web of Science CSD CrossRef CAS IUCr Journals Google Scholar
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555–1573. CrossRef CAS Web of Science Google Scholar
Betz, R. & Gerber, T. (2011). Acta Cryst. E67, o2039. Web of Science CSD CrossRef IUCr Journals Google Scholar
Etter, M. C. (1990). Acc. Chem. Res. 23, 120–126. CrossRef CAS Web of Science Google Scholar
Giner-Sorolla, A. & Bendich, A. (1958). J. Am. Chem. Soc. 80, 5744–5752. CAS Google Scholar
Kohila, V., Jaiswal, A. & Ghosh, S. S. (2012). Med. Chem. Commun. 3, 1316–1322. Web of Science CrossRef CAS Google Scholar
Louis, T., Low, J. N. & Tollin, P. (1982). Cryst. Struct. Commun. 11, 1059–1064. CAS Google Scholar
Nirmalram, J. S., Tamilselvi, D. & Muthiah, P. T. (2011). J. Chem. Crystallogr. 41, 864–867. Web of Science CSD CrossRef CAS Google Scholar
Perumalla, S. R. & Sun, C. C. (2014). J. Pharm. Sci. 4, 1126–1132. Web of Science CrossRef Google Scholar
Prabakaran, P., Murugesan, S., Muthiah, P. T., Bocelli, G. & Righi, L. (2001). Acta Cryst. E57, o933–o936. Web of Science CSD CrossRef IUCr Journals Google Scholar
Quintal, S. M. O., Nogueira, H. I. S., Felix, V. & Drew, M. G. B. (2000). New J. Chem. 24, 511–517. Web of Science CSD CrossRef CAS Google Scholar
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Web of Science CrossRef CAS IUCr Journals Google Scholar
Soares-Santos, P. C. R., Nogueira, H. I. S., Rocha, J., Félix, V., Drew, M. G. B., Sá Ferreira, R. A., Carlos, L. D. & Trindade, T. (2003). Polyhedron, 22, 3529–3539. Web of Science CSD CrossRef CAS Google Scholar
Spek, A. L. (2009). Acta Cryst. D65, 148–155. Web of Science CrossRef CAS IUCr Journals Google Scholar
Tutughamiarso, M., Wagner, G. & Egert, E. (2012). Acta Cryst. B68, 431–443. Web of Science CSD CrossRef CAS IUCr Journals Google Scholar
Vermes, A., Guchelaar, H. J. & Dankert, J. (2000). J. Antimicrob. Chemother. 46, 171–179. Web of Science CrossRef PubMed CAS Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.